The Five Habits of Top Performing Pharma CEOs on LinkedIn

Key Findings Post content regularly Regularly posted content is key to sustaining audience interest and engagement. Maintain consistent posting intervals Consistent posting intervals develop a hunger for content, making one’s audience likely to engage with new posts. Audience size is only part of the picture Audience size is important but is more often an indicator […]

Notable Social Voices on First Drugs Picked for Medicare Price Negotiations

HHS’ announcement of the first 10 drugs selected for Medicare price negotiation touched off a deluge of social conversation on drug pricing reform from lawmakers, journalists, and other groups. For concerned drug makers, the list’s Aug. 29th release was a watershed moment for corporate reputation, especially for Janssen, BMS, and Amgen, whose drugs received the […]

Here are the Top 6 Pharma Journalists that Focus on Health Equity

Building mutually beneficial relationships with key journalists requires the ability to measure influence at a granular (or topical) level. Utilizing Reputos, our influencer advocacy tool, StratInt Research developed a list of the top six pharma journalists on health equity, grouping authors into two buckets based on audience size (10K-100K followers and 1K-10K followers). In addition […]

Senate HELP Committee Hearing on Moderna Vaccine Pricing: Defining and Scoring Participants in the Social Conversation

Members of the Senate Committee on Health, Education, Labor, and Pensions (HELP) questioned Moderna CEO Stephane Bancel on Wednesday, March 22 about the company’s plan to increase the price of its COVID-19 vaccine. As is typical of pharma hearings, Bancel’s testimony generated numerous attention-grabbing headlines in traditional media from a variety of high-profile sources: “Democrats […]

Journalists on FDA Approvals: Building a Proactive Engagement Strategy for A Marketing Campaign

Following years of R&D investment in a medicine, an FDA approval is a major financial victory for a drug maker. Without one, a pharmaceutical company cannot market a drug with medical claims. Accordingly, an approval is the ideal opportunity for a company’s communications team to execute on a carefully crafted media engagement strategy that results […]

Senate Finance Committee on Corporate Taxes: Identifying the Influential Voices on Social Media

Big Pharma’s tax practices are the subject of a multiyear investigation by the Senate Finance Committee, with lawmakers targeting Merck, Bristol Myers Squibb, AbbVie, Abbott, and Amgen for financial details. The hot-button issue of taxes is reputationally risky for any corporation but the nexus between the pharmaceutical industry’s tax practices and drug prices, a topic […]